Theranostic application of miR-429 in HER2+ breast cancer
Sign Up to like & getrecommendations! Published in 2020 at "Theranostics"
DOI: 10.7150/thno.36274
Abstract: Human epidermal growth factor receptor 2 (HER2) is overexpressed/amplified in one third of breast cancers (BCs), and is associated with the poorer prognosis and the higher metastatic potential in BC. Emerging evidences highlight the role… read more here.
Keywords: breast; mir 429; application mir; theranostic application ... See more keywords